Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Panzem 2-methoxyestradiol: Phase I data; Phase II

In an NCI-sponsored U.S. Phase I trial in 17 patients with advanced solid tumors,

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE